Part 1 - What Is Cancer
C. Norman Coleman, MD
C. Norman Coleman, MD, is director of the Radiation Oncology Sciences Program for the
National Cancer Institute in Bethesda, Md. He also serves the NCI as chief of the Radiation
Oncology Branch and deputy director of the Center for Cancer Research, among other positions.
He earned his bachelor’s degree from the University of Vermont and medical degree from Yale.
He completed his internship and residency at the University of California in San Francisco and at
the NCI. He served on the staff of Stanford University’s School of Medicine before joining
Harvard Medical School in 1985. He joined the NCI in 1999. He is the author of “Understanding
Cancer: A Patient’s Guide to Diagnosis, Prognosis and Treatment,” published in 1998.
Andrew C. Von Eschenbach, MD
Andrew C. Von Eschenbach, MD, was named director of the National Cancer Institute in
December 2001. Previously, he was a research director at the University of Texas M.D. Anderson
Cancer Center. A urologist by training and a cancer survivor himself, he earned his bachelor’s
degree from St. Joseph’s University in Philadelphia, and his medical degree from Georgetown
University Medical School. He completed residencies at Pennsylvania Hospital in Philadelphia
before becoming an instructor in urology at the University of Pennsylvania Medical School.
Mark A. Israel, MD
Mark A. Israel, MD, since October 2001 has been director of the Norris Cotton Cancer Center at
Dartmouth-Hitchcock Medical Center in Lebanon, N.H. Previously, he was the Kathleen M. Plant
Distinguished Professor and Director of the Preuss Laboratory of Molecular Neuro-Oncology at
University of California at San Francisco, where he had been a faculty member since 1990. A
leading expert on childhood brain tumors, Israel graduated from Hamilton College and the Albert
Einstein College of Medicine. Following his training in pediatrics at the Children's Hospital
Medical Center in Boston, he was recruited to the National Institutes of Health, where he rose to
head the Molecular Biology Section (formerly molecular genetics) in the Pediatric Branch of the
National Cancer Institute.
Christopher H. Lowrey, MD
Christopher H. Lowrey, MD, is acting section chief of the Section of Hematology/Oncology of
the Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center. He joined the faculty
of Dartmouth Medical School in 1993, and has been co-director of the Hem/Onc Fellowship
Program in charge of research since 1996. He earned his bachelor’s degree from Bowdoin
College, his master’s from the University of Pennsylvania, and his medical degree from Boston
University. He completed his residency at the New England Medical Center and the National
Institutes of Health.
Part 2 - Voices
Julia Rowland, PhD
Julia Rowland, PhD, was appointed director of NCI’s Office of Cancer Survivorship in
September 1999. Before coming to DCCPS, she was the founding director of the Psycho-
Oncology Program at the Lombardi Cancer Center at Georgetown University (1990-1999). Prior
to that, she trained and worked for 13 years in psycho-oncology at Memorial Sloan-Kettering
Cancer Center (MSKCC). Dr. Rowland received her PhD in developmental psychology from
Columbia University in 1984 and was one of the first two post-doctoral fellows at MSKCC to
receive NIH-supported training in the then newly-emergent field of psychosocial oncology.
While at MSKCC, where she held joint appointments in pediatrics and neurology, Dr. Rowland
helped establish and was the first director of the Post-treatment Resource Program.
Her research has focused on both pediatric and adult cancer survivorship. She has published
extensively on women’s reactions to breast cancer, as well as on the roles of coping, social
support, and developmental stage in a patient’s adaptation to cancer. She co-edited the
groundbreaking text, Handbook of Psychooncology: Psychological Care of the Patient with
Cancer (1989), and is the author of more than 75 scientific articles, reviews, and book chapters.
Lisa A. Szczepaniak, ARNP, MSN
Lisa A. Szczepaniak, ARNP, MSN, is Director of Clinical Services, Palliative Medicine at
Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. She earned her masters in
science of nursing degree from Kent State University in Ohio and her nurse practitioner degree at
the University Hospitals of Cleveland.
Part 3 - New Directions
O. Ross McIntyre, MD
Dr. McIntyre was director of Norris Cotton Cancer Center in New Hampshire from 1975-1992.
As chair of the Cancer and Leukemia Group B, he assisted in the early development of cancer
treatment trials. He is a graduate of Dartmouth College, Dartmouth Medical School, and Harvard
Medical School. His work for the last several years has focused on the design, implementation,
and analysis of large cancer treatment trials with particular emphasis on leukemia and multiple
myeloma. He maintains an interest in cancer epidemiology, screening and prevention, and
psychosocial studies in cancer.
Richard Stone, MD
Dr. Stone is clinical director, Adult Acute Leukemia Program at the Dana-Farber Cancer Institute
(DFCI) and associate professor of medicine at Harvard Medical School. He received his MD in
1981 from Harvard Medical School, his internal medicine residency training at Brigham and
Women's Hospital, and his hematology-oncology fellowship at DFCI. He has performed
numerous laboratory and clinical studies on acute leukemia and related disorders, and frequently
participates in grand rounds worldwide. He is currently the clinical director of the Adult Acute
Leukemia Program at DFCI and is vice chair of the Leukemia Core Committee for the national
cooperative trials group Cancer and Leukemia Group B.
Gary Gilliland, PhD, MD
Dr. Gilliland studies the genetics and pathophysiology of human hematologic malignancies, with
the goal of translating these findings into improved outcomes for patients. He is professor of
medicine at Brigham and Women's Hospital and Harvard Medical School; a member of the
faculty of the department of Genetics in the graduate school of Biomedical and Biological
Sciences, also at Harvard Medical School; director of the Leukemia Program at the Dana-Farber/
Harvard Cancer Center; and attending physician at Brigham and Women's Hospital and the Dana-
Farber Cancer Institute. He is a residential member of the Harvard Institute of Human Genetics.
Dr. Gilliland received his Ph.D. degree in microbiology at the University of California, Los
Angeles, under the mentorship of R. John Collier, and his M.D. degree from the University of
California, San Francisco. He trained in internal medicine and was chief medical resident at
Brigham and Women's Hospital. His fellowship training in hematology and oncology was done at
Brigham and Women's Hospital and the Dana-Farber Cancer Institute.
Richard J. Barth Jr. MD
Dr. Barth is associate professor of surgery at Dartmouth Medical School and section chief for
general surgery at Dartmouth-Hitchcock Medical Center. Among his clinical interests are
surgical oncology and immunotherapy for colon and rectal cancer. Dr. Barth received an A.B. in
Biochemical Sciences from Princeton in 1981, and an M.D. from Harvard Medical School in
1985. During the middle of his surgical residency at the New England Deaconess Hospital, he
spent 2.5 years in the laboratory of Dr. Steven Rosenberg at the National Cancer Institute. Dr.
Barth joined the faculty of Dartmouth Medical School in 1993. Dr. Barth's lab is investigating
the immune response to tumors to develop more effective vaccines.
Eric C. Larsen, MD
Eric C. Larsen, MD, is director of the Division of Pediatric Hematology-Oncology at Dartmouth-
Hitchcock Medical Center and a member of the Immunology and Cancer Immunotherapy
Research Program at Norris Cotton Cancer Center in Lebanon, NH. He is Associate Professor of
Pediatrics at Dartmouth Medial School, having joined the faculty in 1990. He earned his
bachelor’s degree at Harvard College and his medical degree from the University of Vermont
College of Medicine.
Randy Noelle, PhD
Dr. Noelle is professor of microbiology and immunology at Dartmouth Medical School and
deputy director of the Norris Cotton Cancer Center, as well as co-director of the center’s
Immunology and Cancer Immunotherapy Research Program. Dr. Noelle was a post-doctoral
fellow at the University of Texas Health Science Center at Dallas from 1980-1984, and in 1984,
he joined the faculty of Dartmouth Medical School as an Assistant Professor. In 1995, he was
promoted to Professor of Microbiology. Dr. Noelle's laboratory has identified a novel membrane
protein expressed on helper T lymphocytes (Th), CD154. Research is focused on how to block a
wide spectrum of immune and autoimmune responses and transplantation rejection.
Daphne Haas-Kogan, MD
Dr. Daphne A. Haas-Kogan is assistant professor of Radiation Oncology at the University of
California San Francisco and a radiation oncologist at the UCSF Comprehensive Cancer Center.
She is an expert in the treatment of pediatric cancers. In addition to caring for patients, she is an
accomplished scientist who investigates the effects of radiation therapy on cancer tumors. Her
work on this subject has been published widely in medical and science journals. Haas-Kogan, a
recipient of numerous awards, completed her medical degree and residency in radiation oncology
at the University of California, San Francisco. She is an assistant professor in radiation oncology
Edward A. Sausville, MD, PhD
Edward A. Sausville, M.D., Ph.D is the associate director of clinical research at the University of
Maryland Greenebaum Cancer Center and a faculty member of the University of Maryland
School of Medicine. Dr. Sausville was previously associate director of the National Cancer
Institute’s Developmental Therapeutics Program, which played a key role in developing many of
the new cancer drugs in use today. Dr. Sausville received his M.D. and a Ph.D. in Pharmacology
from the Albert Einstein College of Medicine in the Bronx, N.Y., in the late 1970s. He completed
his residency at Brigham & Women’s Hospital in Boston in 1982 and a three-year fellowship in
the clinical oncology program at the National Cancer Institute in 1985. He then was an attending
physician at the U.S. Naval Hospital in Bethesda and Georgetown University Hospital in
Washington before returning to the National Cancer Institute in 1990. He has served as associate
director of NCI’s Developmental Therapeutics Program since 1994. The Developmental
Therapeutics Program is involved in all aspects of drug development from the initial discovery of
an agent in a basic research laboratory to wide-scale testing in a national clinical trial. NCI
collaborates with government laboratories, research institutes, academic institutions and
companies throughout the world in its search for new compounds.
Alan H. Siegel, MD
Alan H. Siegel, MD is Director of Nuclear Medicine at Dartmouth-Hitchcock Medical Center and
is Associate Professor of Radiology at Dartmouth Medical School. He received his bachelors
degree from Haverford College in Haverford, PA and his medical degree from Mount Sinai
Medical School in New York. Dr. Siegel completed his residency at Beth Israel Medial Center in
New York and did a fellowship in Nuclear Medicine at the University of Pennsylvania.
Part 4 - Prevention and Screening
Otis W. Brawley , MD
Dr. Otis W. Brawley is professor of medicine of Hematology and Oncology at the Emory
University School of Medicine and professor of Epidemiology at the Emory Rollins School of
Public Health. He also serves as associate director of the Winship Cancer Institute at Emory
University and as director of the Georgia Cancer Center of Excellence at Grady. Dr. Brawley's
interest in the dissemination of medical knowledge has extended to ethical issues and the
availability of new knowledge and technologies to socio-economically disadvantaged
communities. His work concerning racial differences in patterns of medical care and the similar
outcomes among racial and ethnic groups when there is equal treatment is widely cited in medical
literature. Prior to Emory, Brawley was assistant director at the National Cancer Institute for its
Office of Special Populations Research. He held an appointment in the Division of Cancer
Prevention and was an attending physician at Bethesda Naval Hospital and the National Institutes
of Health Clinical Center.
Neil Benowtiz, MD
Dr. Benowitz, a professor of medicine, psychiatry, and pharmacy at the University of California
at San Francisco, is one of the world's experts on the effects of nicotine and how it is broken
down in the blood and removed from the body. His research has helped explain the addictive
nature of nicotine and tobacco and the role nicotine and other substances in tobacco smoke play
in various diseases. Dr. Benowitz began studying nicotine and its effects on people in 1975 when
that area of research was in its infancy. His early investigations showed how nicotine behaves in
the blood and how it is metabolized or broken down by the body. Dr. Benowitz's research has
influenced policy and treatment strategies. For example, his research on nicotine addiction among
young people contributed to greater restrictions on smoking in schools.
Robert A. Smith, PhD
Robert Smith is a cancer epidemiologist and director of Cancer Screening at the National Office
of the American Cancer Society (ACS) in Atlanta, Georgia. He also is adjunct professor of
Epidemiology at the Emory School of Public Health. Prior to joining the staff at the ACS, he held
positions with the Centers for Disease Control and the Boston University School of Public
Health. He has served on many national and federal advisory committees and working groups,
and is the co-chair of the National Colorectal Cancer Roundtable. Currently, he serves on the
Center for Medicare and Medicaid Services Breast Cancer Expert Group, the Centers for Disease
Control's Breast and Cervical Cancer Early Detection and Control Advisory Committee, and he is
chair of the Data Safety and Monitoring Committee for the Digital Mammography Trial. In 1995,
he was made an Honorary Fellow of the Society of Breast Imaging.
Peter Greenwald, MD, Dr. PH
Dr. Greenwald is director of the Division of Cancer Prevention and Control at the National
Cancer lnstitute, NIH. Before assuming that position in 1981, he was director of the Cancer
Control Bureau, NY State Department of Health; director of the Epidemiology and Disease
Control Study Section, of the NIH, and director of the Division of Epidemiology, NYS Dept. of
Bruce Ames, PhD
Dr. Ames is a professor of Biochemistry and Molecular Biology, University of California,
Berkeley , and a senior scientist at Children's Hospital Oakland Research Institute (CHORI).
Among other things, he is the discoverer of the Ames Test, used to detect and determine
carcinogens. He is a member of the National Academy of Sciences and was on their Commission
on Life Sciences. He was a member of the board of directors of the National Cancer Institute, the
National Cancer Advisory Board, from 1976 to 1982. He was the recipient of the General Motors
Cancer Research Foundation Prize (1983), the Tyler Environmental Prize (1985), the Gold Medal
Award of the American Institute of Chemists (1991), the Glenn Foundation Award of the
Gerontological Society of America (1992), the Lovelace Institutes Award for Excellence in
Environmental Health Research (1995), the Honda Prize of the Honda Foundation, Japan (1996),
the Japan Prize, (1997), the Kehoe Award, American College of Occup. and Environ. Med.
(1997), the Medal of the City of Paris (1998), the U.S. National Medal of Science (1998), The
Linus Pauling Institute Prize for Health Research (2001), and the American Society for
Microbiology Lifetime Achievement Award (2001). His over 450 publications have resulted in
his being among the few hundred most-cited scientists (in all fields).
Ross Hammond is an independent consultant based in San Francisco, and an internationally
recognized expert in tobacco control. His focus is on the international dimensions of the tobacco
epidemic. He has a masters degree in Applied Economics from American University. He is
closely associated with the Campaign for Tobacco Free Kids. Before coming to tobacco control,
he worked on a number of different international issues, from the reform of the international
financial institutions, to the refugees’ crisis in the Horn of Africa, to the role of NGOs in
international advocacy. Over the past 15 years he has worked in East Africa, Washington, DC and
at UN headquarters in New York.
Lynn Butterly, MD
Dr. Butterly is a gastroenterologist at Dartmouth-Hitchcock Medical Center and an associate
professor of medicine at Dartmouth Medical School. She has a special interest in colon cancer,
risk assessment for colorectal cancer, and screening for colorectal cancer or polyps. She is well
known for her promotion of education for colon cancer screening. Dr. Butterly is a graduate of
Harvard Medical School and has held teaching appointments at Harvard Medical School, Tufts
University School of Medicine, and currently at Dartmouth Medical School.